Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 11 of 14, showing 5 Applications out of 67 total, starting on record 51, ending on 55

# Protocol No Study Title Investigator(s) & Site(s)

51.

ECCT/18/07/06   Hestia 3
    A Randomised, Double-Blind, Parallel-Group, Multicentre, Phase III Study to Evaluate the Effect of Ticagrelor versus Placebo in Reducing the Rate of Vaso-Occlusive Crises in Paediatric Patients with Sickle Cell Disease   
Principal Investigator(s)
1. Prof Jessie Nyokabi Githanga
2. Videlis Nduba
3. Janet N Oyieko
4. Bernards Ragama Ogutu
Site(s) in Kenya
1. Gertrude’s Children’s Hospital (Nairobi City county)
2. Chandaria Health Center Clinical Research Clinic (Nairobi City county)
3. Kenya Medical Research Institute (KEMRI) Kisumu (Kisumu county)
4. KEMRI Kombewa Clinical Research Centre (Nairobi City county)
5. Kondele Children\'s Hospital (Kisumu county)
6. Strathmore University Medical Centre (Nairobi City county)
 
View

52.

ECCT/18/07/05   A Multi-country, Prospective, Clinical Safety Study of Subjects Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
    A Multi-country, Prospective, Clinical Safety Study of Subjects Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo       
Principal Investigator(s)
1. Fredrick Sawe
2. Janet Oyieko
Site(s) in Kenya
1. Kenya Medical Research Institute/Walter Reed Project, Clinical Research Centre (Kericho county)
2. KEMRI/WRP Kisumu, Kenya at the Kombewa Clinical Research Centre (Kisumu county)
 
View

53.

ECCT/18/05/03   RV 392
    Antiretroviral Therapy for Acute or Early HIV Infection   
Principal Investigator(s)
1. Deborah Chepngeno Langat
Site(s) in Kenya
KEMRI WRP, Kericho
 
View

54.

ECCT/17/09/03   A5354
    Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses   
Principal Investigator(s)
1. Deborah Langat
Site(s) in Kenya
Kenya Medical Research Institute Walter Reed Project Clinical Research Centre
 
View

55.

ECCT/17/09/02   WHO ACTION-I and ACTION-2 Trial
    A65913: A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries to improve newborn outcomes       A65916: A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes   
Principal Investigator(s)
1. Frederick Were
2. John Kinuthia
3. Zahida Parveen Qureshi
4. Zahida Parveen Qureshi
5. Zahida Parveen Qureshi
Site(s) in Kenya
1. Coast Provincial General Hospital (Mombasa Level 5 Hospital) (Mombasa county)
2. Kiambu Level 4 Hospital (Kiambu county)
3. Thika Level 5 Hospital (Kiambu county)
4. Nakuru Level 5 Hospital (Nakuru county)
 
View